We are live on
!
Find out more
VanEck Biotech ETF
BBH
BBH
108 hedge funds and large institutions have $123M invested in VanEck Biotech ETF in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $131M → $123M (-$8.66M)
17% less call options, than puts
Call options by funds: $1.16M | Put options by funds: $1.39M
Holders
108
Holding in Top 10
–
Calls
$1.16M
Puts
$1.39M
Top Buyers
| 1 | +$3.2M | |
| 2 | +$2.65M | |
| 3 | +$2.04M | |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$886K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$576K |
Top Sellers
| 1 | -$20.2M | |
| 2 | -$2.21M | |
| 3 | -$946K | |
| 4 |
LPL Financial
San Diego,
California
|
-$407K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$231K |